Caplight Logo









Inherent Biosciences, Inc.

Inherent Biosciences, Inc.

Private
Salt Lake City, UtahHealthcare & Life Scienceshttps://inherentbio.com

Last Round

VC Round

Dec 12, 2023

Total Funding Raised

$2.41M

Momentum Score

50 /100

Company Overview

Inherent Biosciences, Inc. is a biotechnology company pioneering an epigenetic medicine platform to develop diagnostics and therapeutics for complex diseases like infertility.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

epigenetic diagnosticsmale infertility testsperm quality testDNA methylation analysisAI diagnosticsfertility techepigenetics platformat-home fertility testprecision medicinereproductive healthbiotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inherent Biosciences, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Inherent Biosciences, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 12, 2023
GrantMay 31, 2023
Series ASep 7, 2022
GrantApr 1, 2022
SeedFeb 17, 2021
Grant
Sep 9, 2020

Key People

Founding team and executive leadership

Andy Olson

Co-founder, CEO

Founding Team

Bryce Daines

Fractional Chief Technology Officer

Executive Team

Lorry O'Loughlin Schneider

Chief Operating Officer

Executive Team

Inherent Biosciences, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Inherent Biosciences, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Inherent Biosciences, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSalt Lake City, Utah
Employee Range12
Year Founded2019
Last FundingDec 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.